Truelixir Life Science Private Limited
About Truelixir Life Science Private Limited
Data last updated:
Truelixir Life Science Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308831. Its GSTIN is 27AAGCT7519J1ZW (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Sunanda Ashok Bedse and Ashok Yadavrao Bedse.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. C – 1 Fivestar MIDC Industrial Area Shendra, Aurangabad, Maharashtra, India – 431007.
As per the financials filed for FY 2024, the company reported a revenue of ₹26.74 Cr, a growth of 85% compared to the previous year. For the same year it recorded a net profit of ₹1.77 Cr (net margin 6.6%) and EBITDA of ₹6.86 Cr (EBITDA margin 25.7%). Revenue has grown at a compounded annual rate (CAGR) of 120% over three years.
The company has about 60 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25.88 Cr on record. Court records list 3 cases involving the company, including 2 filed against it; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. C – 1 Fivestar MIDC Industrial Area Shendra, Aurangabad, Maharashtra, India – 431007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Truelixir Life Science Private Limited
The main business activity of Truelixir Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Truelixir Life Science Private Limited FY 2025 filings available
Truelixir Life Science Private Limited reported revenue of ₹26.74 Cr (up 85% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Truelixir Life Science Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 120% over three years, including 85% growth in the latest year. EBITDA rose 226% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Truelixir Life Science Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹26.74 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.77 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Truelixir Life Science Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Truelixir Life Science are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Truelixir Life Science Private Limited
Truelixir Life Science Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vpam Healthcare Private Limited | ₹27 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
| God Gift Laboratory Private Limited | ₹26.95 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Punjabi Bagh, Delhi, India |
| Elikem Pharmaceuticals Private Limited | ₹26.94 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kalol, Gujarat, India |
| Inzpera Healthsciences Limited | ₹26.85 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Nysa Biomed Private Limited | ₹26.79 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Satara, Maharashtra, India |
| Truelixir Life Science Private Limited this company | ₹26.74 Cr (FY 2024) | •••• | •••• | 85.0% | •••• | Aurangabad, Maharashtra, India |
| Iva Healthcare Private Limited | ₹26.73 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Chandigarh, India |
| Boots Lifesciences Limited | ₹26.72 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Bangalore, Karnataka, India |
| Nri Vision Care India Limited | ₹26.69 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Therdose Pharma Private Limited | ₹26.66 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Virjo Healthcare Private Limited | ₹26.63 Cr (FY 2025) | •••• | •••• | 657.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Truelixir Life Science by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Truelixir Life Science Private Limited
Truelixir Life Science Private Limited is audited by Ashok Patil & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ashok Patil & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Truelixir Life Science Private Limited
Truelixir Life Science has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunanda Ashok Bedse Also directs: Bedse Pulp Conversion Industries Pvt Ltd | Director | 29 Apr 2019 | 7 Years 5 Months | Current |
| Ashok Yadavrao Bedse Also directs: Bedse Pulp Conversion Industries Pvt Ltd | Director | 02 May 2018 | 8 Years 5 Months | Current |
| Harsh Arun Tanpure Also directs: Sai Bhagirathi Elite Private Limited | Director | 26 Mar 2022 | 4 Years 6 Months | Current |
| Kailash Sonaji Borade Also directs: Govind Ganga Farmers Producer Company Limited | Director | 02 May 2018 | 8 Years 5 Months | Current |
| Nilesh Ashok Patil Also directs: Bedse Pulp Conversion Industries Pvt Ltd | Director | 02 May 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of Truelixir Life Science Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Truelixir Life Science Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2024 | Others | ₹40 Lakh | Open |
| 28 Dec 2022 | Others | ₹2.5 Cr | Open |
| 30 Dec 2020 | Others | ₹3 Cr | Open |
| 31 May 2019 | Others | ₹1.48 Cr | Open |
| 31 May 2019 | Others | ₹9.85 Lakh | Open |
Total charge records: 12 View all charges
Legal Cases of Truelixir Life Science Private Limited
Truelixir Life Science Private Limited has 3 court cases on record: 2 filed against it, 1 where it is another party. 1 case is pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln IDA) | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Aurangabad, Maharashtra | Civil suit | Company is another party | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Truelixir Life Science Private Limited
Truelixir Life Science Private Limited has a workforce of 60 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Truelixir Life Science Private Limited
Truelixir Life Science Private Limited has 7 board changes on record since 2018: 5 appointments and 2 cessations. The latest: Harsh Arun Tanpure ceased to be Additional Director on 12 Sep 2022.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Truelixir Life Science Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Truelixir Life Science Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Truelixir Life Science Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Truelixir Life Science Private Limited
Truelixir Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCT7519J1ZW | Maharashtra | Active | 26 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Truelixir Life Science Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truelixir Life Science Private Limited
Truelixir Life Science is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2018 (8+ years old) and is registered under CIN U74999MH2018PTC308831.
Truelixir Life Science reported revenue of ₹26.74 Cr for FY 2024 (up 85% YoY).
Truelixir Life Science has 5 current directors:
- Sunanda Ashok Bedse - Director
- Ashok Yadavrao Bedse - Director
- Harsh Arun Tanpure - Director
- Kailash Sonaji Borade - Director
- Nilesh Ashok Patil - Director
Truelixir Life Science reported a net profit of ₹1.77 Cr (net margin 6.6%) and EBITDA of ₹6.86 Cr (EBITDA margin 25.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Truelixir Life Science is 120% over three years. In the latest year (FY 2024) revenue rose 85%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Truelixir Life Science is 27AAGCT7519J1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Truelixir Life Science is U74999MH2018PTC308831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Truelixir Life Science has 3 court cases on record: 2 filed against it. 1 is pending.
Truelixir Life Science was incorporated on 02 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Truelixir Life Science by revenue are Vpam Healthcare Private Limited, God Gift Laboratory Private Limited, Elikem Pharmaceuticals Private Limited, Inzpera Healthsciences Limited, Nysa Biomed Private Limited and 5 more, all in the Pharma industry (Formulations).
Harsh Arun Tanpure ceased to be Additional Director on 12 Sep 2022. Harsh Arun Tanpure was appointed as Director on 26 Mar 2022. Sudhir Ramchandra Naik ceased to be Director on 29 Apr 2019. Truelixir Life Science has 7 board changes on record in total.